DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on July 30, 2007; DOI: 10.1124/dmd.107.015800


0090-9556/07/3511-1996-2005$20.00
DMD 35:1996-2005, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.015800v1
35/11/1996    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maeng, H.-J.
Right arrow Articles by Chung, S.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maeng, H.-J.
Right arrow Articles by Chung, S.-J.

Functional Induction of P-glycoprotein in the Blood-Brain Barrier of Streptozotocin-Induced Diabetic Rats: Evidence for the Involvement of Nuclear Factor-{kappa}B, a Nitrosative Stress-Sensitive Transcription Factor, in the Regulation

Han-Joo Maeng, Mi-Hwa Kim, Hyo-Eon Jin, Sang Mi Shin, Takasi Tsuruo, Sang Geon Kim, Dae-Duk Kim, Chang-Koo Shim, and Suk-Jae Chung

Department of Pharmaceutics, College of Pharmacy (H.-J.M., M.-H.K., H.-E.J., D.-D.K., C.-K.S., S.-J.C.), and National Research Laboratory, College of Pharmacy and Research Institute of Pharmaceutical Sciences (S.M.S., S.G.K.), Seoul National University, Seoul, Korea; and Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan (T.T.)

The objective of this study was to investigate the transport kinetics of cyclosporin A, a well known substrate for P-glycoprotein (P-gp), across the blood-brain barrier (BBB), and the expression of the transporter in the brain of streptozotocin-induced diabetic rats. The in vivo transport clearance of cyclosporin A was significantly reduced in diabetic rats compared with that in the control. The decreased transport was associated with the increased level of mRNA and the protein for P-glycoprotein in the rat brain. The functional activity of the efflux transporter in mouse brain capillary endothelial (MBEC4) cells, an in vitro model of the BBB, was also stimulated when slow nitric oxide (NO)-releasing donors were present, whereas the stimulation was absent in the case of rapid NO-releasing donors (e.g., S-nitroso-N-acetyl-dl-penicillamine and diethylenetriamine). The stimulatory effect was highest for sodium nitroprusside (SNP) and the functional induction associated with the increased mRNA and protein level of the transporter. The pretreatment of the cell with SNP along with ascorbate, methylene blue, or superoxide dismutase attenuated the induction of function and expression for P-glycoprotein, suggesting that the reaction product between superoxide and NO is involved in the induction of function and expression. The level of nuclear translocation of nuclear factor-{kappa}B (NF-{kappa}B) and DNA binding activity of nuclear extracts to the NF-{kappa}B consensus oligonucleotide was increased in MBEC4 cells pretreated with SNP. Taken together, these observations suggest that nitrosative stress leads to the up-regulation of the message for the efflux transporter and, ultimately, to the enhanced function, probably via a NF-{kappa}B-dependent mechanism.


Address correspondence to: Dr. Suk-Jae Chung, Department of Pharmaceutics, College of Pharmacy, Seoul National University, San 56-1 Shinlim-dong, Kwanak-gu, Seoul 151-742, Korea. E-mail: sukjae{at}plaza.snu.ac.kr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.